07/11/2022 - Mirum Pharmaceuticals Inc.: Mirum Presents New Data from LIVMARLI Phase 3 PFIC Study and ALGS Infant Study in Late-Breaker Presentations at The Liver Meeting of AASLD

[X]
Mirum presents new data from livmarli phase 3 pfic study and algs infant study in late-breaker presentations at the liver meeting of aasld

The text version of this document is not available. You can access the original document here.

Disclaimer

Mirum Pharmaceuticals Inc. published this content on 07 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 November 2022 18:09:10 UTC.

MoneyController ti propone anche

Condividi